Tag: COTI-219

October 18, 2017

Critical Outcome Closes Second Tranche of Private Placement

Critical Outcome Technologies announced the closing of the second tranche of a $2 million non-brokered private placement.
October 12, 2016

Critical Outcome Technologies Announces Next Clinical Candidate, COTI-219, Targeting KRAS

Critical Outcome Technologies, a clinical-stage biopharmaceutical company advancing innovative and targeted therapies for the treatment of cancer, announced today that...
August 3, 2016

Critical Outcome Technologies Reports Year-End Financial & Operating Results

LONDON, ON–(Marketwired – August 03, 2016) – Critical Outcome Technologies Inc. (“COTI” or the “Company”) (TSX VENTURE: COT) (OTCQB: COTQF),...